The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 27, 2016

Filed:

Jun. 28, 2013
Applicants:

Heather Davis, Donrobin, CA;

Risini Weeratna, Ottawa, CA;

Inventors:

Heather Davis, Donrobin, CA;

Risini Weeratna, Ottawa, CA;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61K 39/00 (2006.01); C07K 14/47 (2006.01); A61K 39/29 (2006.01); C07K 14/005 (2006.01); C07K 14/31 (2006.01); C12N 7/00 (2006.01); A61K 39/12 (2006.01);
U.S. Cl.
CPC ...
C07K 14/47 (2013.01); A61K 39/00 (2013.01); A61K 39/0011 (2013.01); A61K 39/12 (2013.01); A61K 39/292 (2013.01); A61K 39/39 (2013.01); C07K 14/005 (2013.01); C07K 14/31 (2013.01); C12N 7/00 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/57 (2013.01); C12N 2710/16634 (2013.01); C12N 2730/10134 (2013.01); C12N 2740/16034 (2013.01); C12N 2760/18534 (2013.01);
Abstract

The invention relates to immunostimulatory oligonucleotides and methods of using immunostimulatory oligonucleotides to induce an antigen-specific immune response. The invention further relates to a vaccine that comprises an immunostimulatory oligonucleotide and an antigen, and comprises a pharmaceutically acceptable carrier. The immunostimulatory oligonucleotides of the invention, in some embodiments, include one or more modified linkage(s).


Find Patent Forward Citations

Loading…